Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29249145 | 0.85 | SMN1; SMN2 (0.40) | SMN1; SMN2SLC22A6GPR84ALDH1A1 | |
| SCHEMBL28355468 | 0.83 | MAPT (0.41) | MAPTTSHR | |
| SCHEMBL26073636 | 0.82 | SMN1; SMN2 (0.38) | SMN1; SMN2SLC22A6ALOX15ALDH1A1TSHR | |
| SCHEMBL29249169 | 0.82 | FAAH (0.47) | SMN1; SMN2GPR84ALDH1A1 | |
| SCHEMBL11865413 | 0.82 | MAPT (0.41) | SMN1; SMN2SLC22A6MAPTGPR84ALOX15 | |
| SCHEMBL19359076 | 0.81 | SMN1; SMN2 (0.48) | SMN1; SMN2SLC22A6MAPTGPR84ALOX15 | |
| SCHEMBL5586418 | 0.81 | SMN1; SMN2 (0.48) | SMN1; SMN2SLC22A6MAPTGPR84ALOX15 | |
| SCHEMBL305577 | 0.81 | SMN1; SMN2 (0.48) | SMN1; SMN2SLC22A6MAPTGPR84ALOX15 | |
| SCHEMBL31289248 | 0.81 | SMN1; SMN2 (0.48) | SMN1; SMN2SLC22A6MAPTGPR84ALOX15 | |
| SCHEMBL11178461 | 0.81 | MAPT (0.36) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8874019-B2 | Image forming method | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2014-10-28 | — | — | US | claimed |
| US-20130202336-A1 | IMAGE FORMING METHOD | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2013-08-08 | — | — | US | claimed |
| CN-111201321-B | Genetically modified isopropyl malate isomerase enzyme complex and preparation of elongated 2-keto acids and C using same5-C10Method for preparing compounds | 陶氏环球技术有限责任公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-114755318-B | Tracing analysis method for natural components in flavoring essence | 浙江中烟工业有限责任公司 | 2024-05-03 | — | — | CN | disclosed |
| US-11883518-B2 | Method for dyeing keratinous material, comprising the use of an organosilicon compound, an hydroxycarboxylic acid ester, a diol and a dyeing compound | HENKEL AG & CO. KGAA (DE) | 2024-01-30 | — | — | US | disclosed |
| CN-116669699-A | Biorenewable elastomeric gel and uses thereof | 迈图高新材料公司 | 2023-08-29 | — | — | CN | disclosed |
| US-20230069450-A1 | PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED BY USING THE PIGMENT SUSPENSION | HENKEL AG & CO. KGAA (DE) | 2023-03-02 | — | — | US | disclosed |
| US-20230059044-A1 | METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, AN HYDROXYCARBOXYLIC ACID ESTER, A DIOL AND A DYEING COMPOUND | HENKEL AG & CO. KGAA (DE) | 2023-02-23 | — | — | US | disclosed |
| CN-114755318-A | Tracing analysis method for natural components in flavoring essence | 浙江中烟工业有限责任公司 | 2022-07-15 | — | — | CN | disclosed |
| US-8874019-B2 | Image forming method | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2014-10-28 | — | — | US | disclosed |
| US-20140303249-A1 | TOPICAL FUNGICIDAL AGENTS FOR TREATING NAIL DISORDERS | BIOEQUAL AG (CH) | 2014-10-09 | — | — | US | disclosed |
| CN-101280229-B | Alcohol fuel additive capable of preventing metal corrosion and inhibiting rubber swelling | YUNCHENG FENGXI NEW ENERGY DEV CO LTD | 2011-05-11 | — | — | CN | disclosed |
| US-20100204323-A1 | ANTIMICROBIAL COMPOSITIONS COMPRISING ORGANIC ACID ESTERS AND METHODS FOR REDUCING VIRUS AND BACTERIAL POPULATIONS USING SUCH COMPOSITIONS | THE DIAL CORPORATION (US) | 2010-08-12 | — | — | US | disclosed |
| US-20100113593-A1 | TOPICAL FUNGICIDAL AGENTS FOR TREATING NAIL DISORDERS | BIOEQUAL NOVA AG (CH) | 2010-05-06 | — | — | US | disclosed |
| US-20090047223-A1 | Improvements in or Related to Organic Compoounds | GIVAUDAN SA (CH) | 2009-02-19 | — | — | US | disclosed |
| CN-101280229-A | Alcohol fuel additive capable of preventing metal corrosion and inhibiting rubber swelling | YUNCHENG FENGXI NEW ENERGY DEV (CN) | 2008-10-08 | — | — | CN | disclosed |
| EP-1966117-A1 | IMPROVEMENTS IN OR RELATED TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007071085-A1 | IMPROVEMENTS IN OR RELATED TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2007-06-28 | — | — | WO | disclosed |
| US-20060241226-A1 | GAP-FILLING CYANOACRYLATE ADHESIVE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2006-10-26 | — | — | US | disclosed |
| US-6740326-B1 | WATER-FREE TOPICAL APPLICATION COMPOSITION FOR TREATMENT OF NAIL DISEASES AND NAIL CARE CONSISTING OF ANTIMYCOTIC AGENT AND LOWER ALKYL ESTER OF LACTIC ACID, MALIC ACID, TARTARIC ACID OR CITRIC ACID AS PENETRATION PROMOTING CARRIER | BIOEQUAL AG (CH) | 2004-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11883518-B2 | Method for dyeing keratinous material, comprising the use of an organosilicon compound, an hydroxycarboxylic acid ester, a diol and a dyeing compound | KRT18, DSG1, DSC1 | SMN1; SMN2 4585/4885SLC22A6 1555/4885MAPT 3814/4885 |
| US-20090047223-A1 | Improvements in or Related to Organic Compoounds | LPO, OTC, OAT | SMN1; SMN2 1471/4885SLC22A6 1247/4885MAPT 3152/4885 |
| US-20100204323-A1 | ANTIMICROBIAL COMPOSITIONS COMPRISING ORGANIC ACID ESTERS AND METHODS FOR REDUCING VIRUS AND BACTERIAL POPULATIONS USING SUCH COMPOSITIONS | CREB1, AMPD1, AMPD3 | SMN1; SMN2 3167/4885SLC22A6 2647/4885MAPT 4491/4885 |
| US-20230069450-A1 | PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED BY USING THE PIGMENT SUSPENSION | KIT, TYR, RCC1 | SMN1; SMN2 3445/4885SLC22A6 2016/4885MAPT 3083/4885 |
| US-20230059044-A1 | METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, AN HYDROXYCARBOXYLIC ACID ESTER, A DIOL AND A DYEING COMPOUND | KRT18, DSG1, DSC1 | SMN1; SMN2 4585/4885SLC22A6 1555/4885MAPT 3814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.